Short answer
Inhibrx Biosciences, Inc. (INBX) filed an 8-K current report with the SEC on September 28, 2026 reporting Item 7.01 (Regulation FD Disclosure). Updated corporate presentation posted September 28, 2026, providing investors with current business and pipeline materials.
Inhibrx Biosciences, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 7.01 · Regulation FD Disclosure
- Updated corporate presentation posted September 28, 2026, providing investors with current business and pipeline materials
- Presentation distributed through conferences and investor meetings under Regulation FD
- Exhibit 99.1 contains substantive presentation materials; no ongoing update obligation by Inhibrx Biosciences
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Inhibrx Biosciences, Inc. 8-K filings
Get the next INBX 8-K as it lands
Follow INBX for push alerts, or ask the research agent what this filing means.